Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pliant Therapeutics (PLRX) Return on Sales (2020 - 2025)

Pliant Therapeutics (PLRX) has disclosed Return on Sales for 6 consecutive years, with 159.92% as the latest value for Q4 2025.

  • Quarterly Return on Sales changed N/A to 159.92% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 57.65% through Dec 2025, changed N/A year-over-year, with the annual reading at 102.11% for FY2023, 8938.0% down from the prior year.
  • Return on Sales for Q4 2025 was 159.92% at Pliant Therapeutics, up from 32.27% in the prior quarter.
  • The five-year high for Return on Sales was 159.92% in Q4 2025, with the low at 688.48% in Q1 2024.
  • Average Return on Sales over 5 years is 48.94%, with a median of 16.8% recorded in 2021.
  • The sharpest move saw Return on Sales plummeted -66029bps in 2024, then soared 75878bps in 2025.
  • Over 5 years, Return on Sales stood at 12.27% in 2021, then crashed by -45bps to 17.84% in 2022, then tumbled by -472bps to 102.11% in 2023, then tumbled by -574bps to 688.48% in 2024, then skyrocketed by 123bps to 159.92% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 159.92%, 32.27%, and 53.52% for Q4 2025, Q3 2025, and Q2 2025 respectively.